We have located links that may give you full text access.
CASE REPORTS
JOURNAL ARTICLE
A Severe Case of Recalcitrant Pompholyx.
Journal of Cutaneous Medicine and Surgery 2015 September
BACKGROUND: Pompholyx is an inflammatory vesiculobullous skin disease of the hands and feet belonging to the spectrum of eczema.
OBJECTIVE: To report a severe case of pompholyx, its clinical presentation, and its management.
METHODS: A medical chart review was conducted on a patient with this condition.
RESULTS: The patient was patch tested according to the North American Contact Dermatitis Group (NACDG) Standard Screening Series, and results were negative. In the past, she was treated with corticosteroid creams as well as narrow band ultraviolet B (UVB), and Psoralen ultraviolet A (PUVA) therapies, and none were beneficial. When the frequency of the episodes increased, methotrexate was introduced but failed to control the condition. Next, mycophenolate mofetil was started and gradually increased to 3.5 g daily along with a separate trial of radiotherapy with marked success.
CONCLUSION: Pompholyx can be challenging to manage, and treatment can involve an assortment of therapies over a prolonged period of time.
OBJECTIVE: To report a severe case of pompholyx, its clinical presentation, and its management.
METHODS: A medical chart review was conducted on a patient with this condition.
RESULTS: The patient was patch tested according to the North American Contact Dermatitis Group (NACDG) Standard Screening Series, and results were negative. In the past, she was treated with corticosteroid creams as well as narrow band ultraviolet B (UVB), and Psoralen ultraviolet A (PUVA) therapies, and none were beneficial. When the frequency of the episodes increased, methotrexate was introduced but failed to control the condition. Next, mycophenolate mofetil was started and gradually increased to 3.5 g daily along with a separate trial of radiotherapy with marked success.
CONCLUSION: Pompholyx can be challenging to manage, and treatment can involve an assortment of therapies over a prolonged period of time.
Full text links
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app